The Centre for Health Economics (CHE) at York University announces two short courses this Spring, both focusing on economic evaluation in different contexts. “Statistical Methods in
Read more...News
Pandya Presents on Low-Value Care
CHDS faculty Ankur Pandya presented “CEA in the USA: A Quantitative Approach to Identify Low-Value Care” at a HPM Research Seminar. Dr. Pandya discussed how in U.S. health policy
Read more...Valuing Mortality Risk Reductions
CHDS faculty Lisa A. Robinson and James K. Hammitt, and research staff Lucy O’Keeffe, recently published “Valuing Mortality Risk Reductions in Global Benefit-Cost Analysis.”
Read more...Decision Science On-Line Course
CHDS Faculty Director Sue J. Goldie and Senior Research Scientist Eve Wittenberg offers the on-line decision science course “RDS 202: Decision Science for Public Health”
Read more...Risk Analysis Course with James Hammitt
What is risk analysis and why is it important in decision science? This February, Professor James K. Hammitt offers the 4-day course “Analyzing Risk: Principles, Concepts, and Applications”
Read more...Inaugural SPH Learning Design Meeting
The CHDS Media Hub team continues its ongoing mission to improve multi-modal pedagogy across the Harvard Chan School through a new partnership between Media Hub Director Jacob Waxman
Read more...Breast Cancer Management Seminar
Natalia Kunst, PhD candidate at the University of Oslo, presented a CHDS lunchtime seminar on “What is the Value of Further Research on the 21-Gene Assay for Breast Cancer Management”.
Read more...Faculty Working Visit
CHDS affiliated faculty Lisa A. Prosser spent two days on-site with Eve Wittenberg collaborating on ongoing research on spillover effects of illness.
Read more...Teaching Benefit-Cost Analysis
Finding interesting and up-to-date work that challenges students to think carefully about difficult methodological issues is a challenge for educators. CHDS faculty Lisa A. Robinson recently
Read more...CHDS at International HPV Meeting
The CHDS Cervical Cancer Team presented new research results at the 32nd International Papillomavirus Conference in Sydney, Australia.
Read more...